Interested in finding out more? Get in touch today
We aim to get back to you within 24 hours.
"True wisdom is less presuming than folly. The wise man doubteth often, and changeth his mind; the fool is obstinate, and doubteth not; he knoweth all things but his own ignorance." - Akhenaton
We develop our own products as well as manage development of drugs & devices for other clients. We also deal with technology transfer and we are always interested in partnerships and can even help with placement
AlphaBeta Pharma has adapted a unique model for R&D guaranteeing minimal overhead costs and the shortest development timeline in order to maximise the return-on-investment for all stakeholders. We operate a virtual R&D structure, between our two offices in London, UK, (mainly early-development) and Istanbul, Turkey (mainly late-development), through strategic alliances and tactical partnerships. We only pay for the services needed and for the duration required, dramatically reducing our costs and accelerating our execution.
We have an expertise in developing medicines for patients treated by specialist physicians, and for discovering new therapies for serious and life-threatening diseases. While we use a traditional model of taking a project through the pre-clinical and clinical trials phases, we also look to partner/acquire projects in later stages of development, offering lower risk for us, and an increased possibility of getting medicines to market more quickly.
Our distinct approaches to R&D mean that we have two teams, not one, working hard to discover and acquire new ways of treating and preventing diseases; our scientists and our business development who are scouting the globe for the best science and opportunities.
We carry out a series of clinical trials to test each investigational drug or medical device for the potential to become a new medicine available for patients in hospitals, pharmacies and drug stores.
Typically involves healthy volunteers. These trials study the safety of the drug and its interaction with the body.
Includes patients with the illness. An investigational drug designed to treat the illness is evaluated on whether the drug shows the effects we are hoping for. Within this phase we also determine the proper dose and further evaluate the safety of the drug.
The largest and the most expensive part of the clinical development program. These studies are designed to provide the substantial evidence of efficacy and safety required for the regulatory agencies to approve the new investigational drug as a medicine and allow it to be marketed to health care professionals and be used by patients.
AlphaBeta Pharma offers Development Consultancy & Due-diligence services for pharmaceutical & biotech companies, governmental bodies and academic institutions regarding drugs, medical devices and technology transfer. This includes either review and/or planning of:
We present various options for our services, from fully contracted-out to fully contingent, on a non-fee basis - instead sharing a portion of future commercial revenues. We commonly cover development/clinical trials costs and can inject funds directly, if necessary, to carry out critical proof-of-concept or technology development work. We can also assist you in raising funds and even help with placement.
All of these services are provided through a one-point-contact via a dedicated Project Manager assigned for your project and sometimes even located in your own country.
Please click here to request more information or to arrange for a possible free face-to-face meeting
AlphaBeta Pharma provides well qualified interim managers, pharmaceutical physicians and scientists for short-term management or in advisory roles; full or part-time and can also help with permanent placements in many areas including:
Our staff is experienced in restructuring and handling organisation changes. They can also provide training and workshops for pharmaceutical & biotech companies, governmental bodies and academic institutions in many areas including:
Please click here to request more information or to discuss your requirements in confidence.